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Abstract
Tumor necrosis factor-like cytokine 1A (TL1A, TNFSF15) is implicated in inflammatory bowel 
disease (IBD), modulating the location and severity of intestinal inflammation and fibrosis. TL1A 
expression is increased in inflamed gut mucosa and associated with fibrostenosing Crohn’s 
disease. Tl1a-overexpression in mice leads to spontaneous ileitis, and exacerbated induced 
proximal colitis and fibrosis. IBD is associated with shifts in the gut microbiome, but the effect of 
differing microbial populations and their interaction with TL1A on fibrosis has not been 
investigated. We demonstrate that the profibrotic and inflammatory phenotype resulting from 
Tl1a-overexpression is abrogated in the absence of resident microbiota. To evaluate if this is due to 
the absence of a unique bacterial population, as opposed to any bacteria per se, we gavaged germ-
free (GF) wild-type and Tl1a-transgenic (Tl1a-Tg) mice with stool from specific pathogen-free 
(SPF) mice and a healthy human donor (Hu). Reconstitution with SPF, but not Hu microbiota, 
resulted in increased intestinal collagen deposition and fibroblast activation in Tl1a-Tg mice. 
Notably, there was reduced fibroblast migration and activation under GF conditions compared to 
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native conditions. We then identified several candidate organisms that correlated directly with 
increased fibrosis in reconstituted mice and showed that these organisms directly impact fibroblast 
function in vitro. Thus, Tl1a-mediated intestinal fibrosis and fibroblast activation are dependent on 
specific microbial populations.
Introduction
Tl1a (a protein encoded by TNFSF15) is a member of the tumor necrosis factor (TNF) 
superfamily that binds to death domain receptor 3 (DR3), expressed on a variety of cell 
types including immune cells, epithelial cells, and fibroblasts (1–5). Modulating an array of 
immune responses, Tl1a can be produced by endothelial cells in response to IL-1β and 
TNFα, by macrophages and dendritic cells in response to Toll-like receptor stimulation, as 
well as in some lymphoid lineage cells (2,3,6–9). A TNFSF15 haplotype is associated with 
higher Tl1a production, increased risk of CD, intestinal fibrostenosis, and greater need for 
surgery (10–13). In mice, constitutive Tl1a expression induced increased collagen deposition 
in the colon without detectable histologic colitis as well as increased collagen deposition in 
the ileum with spontaneous ileitis (14–17). Under colitogenic conditions induced by chronic 
DSS treatment or adoptive T-cell transfer, there was increased collagen deposition with 
fibrostenotic lesions in the gut that caused intestinal obstruction in the Tl1a-Tg mice (12). 
These results support the role of Tl1a in fibrogenesis that can lead to fibrostenosis in the 
setting of chronic inflammation, which is a common complication of CD leading to 
resection.
The intestinal microbiome has been linked with many inflammatory diseases including IBD 
(18–21). Although previous studies have found alterations in various bacterial taxa in IBD 
patients, and a recent study found an association with a fibrostenotic disease cohort, none 
have correlated specific microbes with degree of fibrosis and fibroblast phenotype (22). 
Most of these studies have been largely associative without the ability (by design) to prove 
causality. The question remains, therefore, whether altered microbiota associated with IBD 
contribute to the disease phenotype or are its consequence. In rodent models, comparison of 
experimental IBD models under GF conditions have yielded disparate results with 
development of colitis in most spontaneous genetically engineered models dependent on 
resident microbiota, or uniquely, potentiated DSS-induced colitis in GF mice (23–25). No 
animal experiments have evaluated the contribution of the microbiome to fibrosis in the 
context of IBD. In this study, we show that the native murine fecal microbiota is required for 
optimal Tl1a-dependent fibroblast activation and transformation into myofibroblasts. 
Moreover, we provide evidence that the intestinal fibrotic phenotype requires specific 
microbial cues provided by mouse microbiota from an SPF facility but absent in human 
feces from a healthy donor. Our analysis further identified several candidate organisms that 
correlate directly with degree of fibrosis in reconstituted hosts and impact fibroblasts in 
vitro. To our knowledge, this is the first study to establish a potential causal role for the 
microbiome in intestinal fibrosis, fibroblast activation and function.
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Results
The intestinal microbiome is required for Tl1a-enhanced intestinal inflammation, collagen 
deposition and fibroblast migration
In agreement with our prior results, Tl1a-Tg mice raised under SPF microbial conditions 
display significant spontaneous ileitis, as evident by increased histopathological scoring 
under H&E, with over a 2-fold increase in average histopathology compared with wild type 
mice (Figure 1A) (16). No histologically apparent cecal inflammation was observed (Figure 
1B). Despite this, Tl1a-Tg mice demonstrate increased cecal collagen deposition (Figure 
1D), underscoring the importance of TL1A as a mediator of fibrosis that can act 
independently of its pro-inflammatory effects.
As the microbiome is relevant to inflammation in several diseases, we evaluated the effects 
of GF conditions on Tl1a-mediated intestinal inflammation. The absence of a microbiome 
abrogated the spontaneous ileitis induced by Tl1a-overexpression, as there were no 
significant differences in ileal histopathology between GF Tl1a-Tg and GF WT mice (Figure 
1A).
We next evaluated if the fibrosis observed in Tl1a-Tg mice was dependent upon the 
microbiome. The absence of microbes significantly reduced ileal and cecal collagen 
deposition in GF Tl1a-Tg mice compared with microbiome intact Tl1a-Tg mice (Figure 1C-
D). No difference was observed in WT mice.
Since we observed notable changes in fibrosis between Tl1a-Tg and WT mice under native 
SPF conditions that were abrogated under GF conditions, we sought to determine the impact 
of Tl1a-overexpression and resident microbiota on fibroblast phenotype. Colonic fibroblasts 
isolated from Tl1a-Tg mice raised under native microbial conditions displayed significantly 
increased migratory capacity after simulated wounding compared with those from WT mice 
(Figure 2A-B). Tl1a-overexpression also increased fibroblast adhesion, which was 
unchanged in GF mice (Supplementary Figure 1). The enhanced rate of fibroblast gap-
closure observed with Tl1a-overexpression under native conditions was eliminated under GF 
conditions, consistent with the observed reduction in histological fibrosis (Figure 2A-B). 
Interestingly, the absence of microbiome reduced fibroblast migratory capacity even in WT 
mice, but to a lesser extent than in Tl1a-Tg mice. These results indicate that the intestinal 
microbiome is required for Tl1a-mediated intestinal fibrosis and influences fibroblast 
migratory function.
An important question arising from these results is whether the observed findings are due to 
direct effects of SPF microbiota and Tl1a (alone or in concert) on fibroblasts themselves, or 
if the microbiome and Tl1a in Tl1a-Tg mice affect other non-fibroblast cell types, which 
then promote fibroblast activation and profibrotic phenotype. Bacterial components and 
products can induce fibroblast activation (26), but it is unclear if they can promote fibroblast 
migration directly. Moreover, the direct effect of bacterial stimulus on fibroblasts in the 
context of host Tl1a-overexpression has not been evaluated. We therefore assessed if 
bacterial products isolated from the cecal luminal washings of native WT SPF mice could 
promote fibroblast migration directly, and if this effect was enhanced by host Tl1a-
Jacob et al. Page 3
Mucosal Immunol. Author manuscript; available in PMC 2019 January 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
overexpression. WT fibroblasts exposed to native SPF cecal washings demonstrate 
significantly increased migration compared to those exposed to cecal washings from GF 
mice (Figure 2C). This direct effect of cecal bacterial components was enhanced by host 
Tl1a-overexpression in Tl1a-Tg mice. Thus, a significant part of the commensal 
microbiome’s effect on fibroblast migration seen in Figure 2A-B may be due to direct 
effects mediated by bacterial components (or products) on fibroblasts themselves.
We next asked if this enhanced migratory phenotype in fibroblasts from Tl1a-Tg mice was 
partly due to direct Tl1a-mediated effects on fibroblasts; namely, can Tl1a promote 
fibroblast migration directly and do so in concert with the direct effect of SPF microbiota on 
fibroblasts seen in Figure 2C? We have previously demonstrated that fibroblasts express the 
Tl1a receptor DR3, and upon treatment with Tl1a in vitro, demonstrate expression of alpha-
smooth-muscle actin (indicative of activation of myofibroblasts) and collagen (27). 
Consequently, fibroblasts treated with Tl1a in vitro demonstrate expression of alph-smooth-
muscle actin (activation to myofibroblasts) and collagen (27). We therefore hypothesized 
that direct stimulation of fibroblasts with Tl1a would increase migration. WT fibroblasts 
treated with Tl1a (and without bacterial components) in vitro displayed significantly 
increased migration compared with untreated cells, suggesting a direct effect of Tl1a on 
fibroblast migration (Figure 2D). To determine if Tl1a can enhance the fibroblast migratory 
response to bacterial components, we conducted the same experiments as in Figure 2C in the 
context of exogenous Tl1a stimulation. WT fibroblasts treated with both Tl1a and SPF cecal 
bacterial products together demonstrated enhanced migration compared with those treated 
solely with the bacterial products (Figure 2D). These data demonstrate that resident bacteria 
and Tl1a can both stimulate fibroblasts, and the direct effect of resident bacteria on 
fibroblasts is enhanced directly by Tl1a.
Gavage with murine but not human fecal microbiota promotes intestinal inflammation and 
collagen deposition in Tl1a transgenic mice
As these data demonstrate that the microbiome is required for Tl1a-mediated fibrosis in 
intestinal regions with and without underlying inflammation, we sought to evaluate if this 
phenotype is due to the absence of a unique bacterial population, as opposed to any bacterial 
colonization per se. We used two distinct microbiota to test the hypothesis that the pro-
fibrotic phenotype observed in Tl1a-Tg mice under native microbial conditions was due to a 
specific bacterial population adapted to the mouse intestine rather than the presence of any 
gut bacteria. GF mice were gavaged with stool collected from wild-type mice housed in SPF 
or with stool from a healthy human (Hu) donor and evaluated 2 months later.
WT mice displayed no increase in intestinal inflammation or collagen deposition when 
colonized with either SPF or Hu flora, indicating that in the absence of Tl1a-overexpression 
the species-specific microbiome does not induce intestinal inflammation or fibrosis (Figure 
3A-D). Tl1a-transgenic mice colonized with SPF microbiota demonstrated increased 
collagen deposition in both inflamed ileum and non-inflamed cecum, consistent with 
findings in mice under native conditions (Figure 3A-D, Figure 1). In contrast, Tl1a-
transgenic recipients of Hu microbiota showed no increase in ileal or cecal collagen 
deposition or inflammation. Together, these data indicate that Tl1a-mediated intestinal 
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fibrosis is modulated by the composition of the intestinal microbiome and suggest that this 
phenotype is induced by microbes selectively contained in the SPF mouse microbiota but 
missing from the human microbiota.
Murine microbiota potentiate Tl1a-mediated intestinal fibroblast differentiation to 
myofibroblasts
Fibroblast activation has been shown to occur after bacterial stimulation e.g. with 
lipopolysaccharide (26). Previously, we showed that there is an increase in the proportion of 
intestinal myofibroblasts in Tl1a-Tg mice raised under conventional SPF conditions (27). 
We investigated whether absence of microbial stimulation (i.e. under GF conditions) impairs 
fibroblast differentiation to myofibroblasts. GF Tl1a-Tg mice did not display an increased 
number or proportion of activated fibroblasts in the cecum compared to GF WT mice 
(Figure 4A-B). Colonization with SPF microbiota induced intestinal myofibroblasts in both 
WT and Tl1a-Tg mice relative to GF conditions or colonization with Hu microbiota (Figure 
4A-B). SPF microbiota, but not Hu microbiota also restored the increased proportion of 
myofibroblasts in Tl1a-Tg mice compared to WT controls (54.7% vs. 36.7%). Interestingly, 
GF Tl1a-Tg mice had reduced myofibroblast proportion compared to GF WT mice, which 
was not seen in the presence of Hu microbiota (Figure 4A-B). These results show that 
fibroblast activation in the cecum induced by Tl1a overexpression is microbiota-dependent 
and that microbial composition affects fibroblast differentiation into myofibroblasts.
To assess whether Tl1a mediated fibroblast activation in the ileum also requires the 
microbiome, we quantitated myofibroblasts in Tl1a-Tg mice under GF conditions. In 
contrast to the cecum, there was an increased proportion of activated myofibroblasts in the 
ileum of GF Tl1a-Tg mice compared with GF WT mice (Figure 4C-D). We next tested 
whether the degree of Tl1a-mediated fibroblast activation is affected by the specific 
microbiome. SPF gavage increased myofibroblast numbers and proportion in both WT and 
Tl1a-Tg mice while preserving the relative increase in myofibroblasts in Tl1a-Tg mice 
(Figure 4C-D). In contrast, mice colonized with Hu microbiota had reduced proportion of 
fibroblast activation compared with GF conditions, suggesting that members of the Hu 
microbiota may have inhibited fibroblast activation. This did not result in significant 
histopathological differences in collagen deposition, however. Taken together, these results 
suggest greater modulation of Tl1a-mediated fibroblast activation by the microbiome in the 
cecum (without concomitant changes in inflammation), for which Tl1a can potentially 
compensate in the ileum, (and in which there is significant increases in inflammation). This 
may reflect distinct microbial communities and mucosal immunity in the ileum, reflected in 
the significant increase in ileal inflammation in Tl1a-Tg mice. Indeed, differing microbial 
composition between the ileum and the cecum has been well-documented in mice and 
humans, including patients with IBD who show distinct microbiome profiles between 
subsets with ileal vs. colonic disease (48). Consistent with this, sequencing of mucosal and 
luminal microbial communities in the ileum and cecum demonstrated distinct microbial 
populations in the ileum vs. the cecum in both Tl1a-Tg and WT mice colonized with SPF 
microbiota (Supplemental Figure 2). These data illustrate biogeographic differences in the 
host-microbe interactions underlying intestinal collagen deposition. Additionally, our data 
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demonstrated that microbial composition modulates the degree of Tl1a-mediated 
myofibroblast activation independent of the intestinal location.
Fibrosis severity is associated with the abundance of specific microbes found in the 
mouse SPF microbiome
Since SPF and Hu microbiota had differential effects on collagen deposition and fibroblast 
activation, we hypothesized that the abundance of specific bacteria would be associated with 
the degree of fibrosis seen in recipient mice. To evaluate this, we performed 16S rRNA 
sequencing to characterize the ileal and cecal microbiome of colonized mice and then 
employed multivariate models to identify microbes with a statistically significant positive or 
negative association with fibrosis score. These microbes were then used to construct co-
occurrence/co-exclusion networks with fibrosis severity to identify the microbes that were 
directly associated with increased or decreased fibrosis rather than merely having a co-
occurrence or co-exclusion relationship with fibrosis-associated microbes. Separate analyses 
were performed of the cecum and ileum of humanized and SPF-colonized ex- GF mice 
(Figure 5). In the cecum of SPF-colonized mice, which demonstrated significant collagen 
deposition and fibroblast activation, we identified several microbes not present in Hu-
gavaged mice that clustered tightly with fibrosis (Figure 5A). This included groups of 
mucolytic bacteria such as Mucispirillum schaedleri and Ruminococcus. Additionally, 
Anaeroplasma were also significantly associated with fibrosis in the cecum of SPF-
colonized mice. Members of Oscillospira and Coprococcus were negatively correlated with 
fibrosis in the cecum (Figure 5A).
In the ileum of SPF-colonized mice, we observed that there were competing sets of microbes 
associated with enhanced or reduced fibrosis severity (Figure 5B). For example, members of 
the Streptococcus and Lactobacillus genera were found to be positively associated with 
fibrosis, whereas Faecalibacterium prausnitzii and members of Bacteroides were negatively 
associated with fibrosis. Consistent with the absence of histological fibrosis, we observed 
only negative correlations between microbial species and fibrosis in both the cecum and 
ileum of Hu-colonized mice (Figure 5C-D).
Differential effects of bacteria positively or negatively correlated with fibrosis on in vitro 
fibroblast function
Next, we determined whether bacterial strains that positively or negatively correlated with 
cecal fibrosis severity in vivo could alter fibroblast function directly in in vitro. Cell lysates 
of Ruminoccocus and M. schaedleri, two bacterial strains that were positively correlated 
with the degree of fibrosis, promoted fibroblast migration and collagen expression compared 
with negatively-correlated Oscillospira, which had comparatively less pronounced effects 
(Figure 6). These results show that microbes that positively or negatively correlate with 
fibrosis in vivo can directly and disparately impact fibroblasts in vitro. Furthermore, one 
potential causal mechanism is now suggested by which specific organisms in the gut 
microbiome mediate fibrosis.
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Discussion
To our knowledge, this is the first study that causally implicates the intestinal microbiome in 
intestinal fibrosis, demonstrating that fibrosis requires the presence of resident microbiota 
and that Tl1a-mediated fibrosis is dependent upon specific bacteria or bacterial consortia. 
Furthermore, we show that microbes that positively or negatively correlate with intestinal 
fibrosis in vivo have direct (and opposing) effects on fibroblast function in vitro. These 
results also suggest that microbiome-TL1A interactions may influence the degree and 
location of intestinal fibrosis in IBD, which has up to now been attributed to the severity of 
inflammation. Accordingly, no histologically significant cecal inflammation was observed 
under SPF microbial conditions but despite this, Tl1a-Tg mice demonstrate increased cecal 
collagen deposition, underscoring the importance of TL1A as a modulator of the location 
and severity of mucosal inflammation, as well as a pro-fibrotic mediator that can act 
independently of its pro-inflammatory effects. Indeed, this disjunction between 
inflammation and fibrosis is clinically significant. While inflammatory disease may be 
associated with significant fibrotic change, as increased inflammation perpetuates the 
cascade of mucosal repair, the frequency of fibrostenosing complications remains significant 
despite immunosuppressive therapy in CD patients in the form of steroids or 
immunomodulators (45). Findings that provide insight into unique pro-fibrotic mediators—
whether cytokine- or microbiome-driven (or both)—are highly relevant for clinical disease.
This theme apparent in the histopathological results was mirrored in our results for fibroblast 
activation, which further underscore the relevance of a pro-fibrotic SPF consortia and Tl1a. 
Given their expression of Toll-like-receptors, fibroblasts have the capacity to become 
activated by bacterial products (26). Consistent with this, Tl1a-mediated fibroblast activation 
required the microbiome in the cecum (despite no concomitant changes in inflammation). 
However, in the ileum, (in which there is significant increase in inflammation), Tl1a could 
partially compensate for the lack of the microbiome and promote some fibroblast activation. 
This might point to unique effects of Tl1a on fibroblast activation that are tissuespecific, but 
may still ultimately require a specific consortium of organisms in SPF to yield 
histopathologically evident fibrosis, as Tl1a-Tg mice still had reduced ileal fibrosis under 
GF conditions and with Humanized microbiome compared with conventional SPF 
microbiota (Figure 1 and 3). The effect of SPF microbiota on ileal fibrosis was not as 
dramatic as in the cecum. One possible explanation for this effect is the differing microbial 
communities that colonize the ileum vs. the cecum. We show that fibrosis correlated much 
more closely with several organisms in the cecum compared with the ileum where there 
were equal positive and negative “pulls” at fibrosis, with a few positively correlated 
organisms and numerous negatively correlated organisms. The organisms that are tightly 
correlated with increased fibrosis in the cecum are less abundant in the ileum. Similarly, the 
ileum harbors numerous organisms that are negatively correlated with fibrosis compared 
with the cecum where there are fewer such organisms. A related potential explanation, is the 
quantity, structure, and type of mucous seen in the small intestine vs. the large intestine. The 
differing mucin composition may account for observed differences in bacterial composition 
in different regions of the gut (49). The mucin-rich large intestine can harbor anaerobic 
organisms with a repertoire of glycosidic enzymes that disassemble complex mucus glycans 
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to be used as a carbon source (50). We identified mucin-degrading bacteria (M. schaedleri) 
to correlate with fibrosis in the cecum. The effect of differing microbial compositions in the 
cecum vs. ileum on fibrosis may be mediated through bacterial modulation of fibroblast 
phenotype, since specific bacteria may have direct and opposing effects on fibroblast, as we 
demonstrated in vitro.
Cecal and ileal colonization with SPF microbiota induced intestinal myofibroblasts in both 
WT and Tl1a-Tg mice relative to GF conditions or colonization with Hu microbiota. 
Notably, however, colonization with SPF microbiota (but not Hu microbiota), in addition to 
Tl1a-overexpression, resulted in overall increased proportion of myofibroblasts. 
Interestingly, GF Tl1a-Tg mice had reduced myofibroblast proportion in the cecum 
compared to GF WT mice, which was not seen in the presence of Hu microbiota. This raises 
the question as to the specific contribution of Tl1a-overexpression vs. microbial changes in 
previously referenced colitigenic models conducted in native microbiome-intact mice (12, 
27). It would, therefore, be important to determine what effects Tl1a-overexpression, 
independent of any bacterial stimulation, but in the presence of other mucosal stimulation, 
such as inflammatory insults due to DSS for example, may have on intestinal fibrosis and 
inflammation; or the effects that differing microbial populations may impart on experimental 
colitis.
These results also have novel implications for a microbiome effect on fibroblast function in 
concert with Tl1a. Consistent with the above noted points regarding the disconnect between 
pro-inflammatory and profibrotic stimuli, colonic fibroblasts do not migrate in response to 
classic pro-inflammatory cytokines such as TNFα or IL-1, but rather require traditionally 
“pro-fibrotic” cytokines such as TGFβ to induce migration (46). It is notable that in our 
migration assay Tl1a significantly and directly increased fibroblast migration compared with 
controls, again suggesting a direct contribution of Tl1a to the pro-fibrotic pathway, which 
may act independently of inflammation. Importantly, our data demonstrate that the gut 
microbiota can promote this effect directly in concert with Tl1a. These findings propose 
novel roles for both Tl1a and SPF microbiota in fibroblast function.
In this study, we utilized a novel correlation of direct changes in fibrosis with specific 
bacterial abundance in a region-specific manner. In the cecum of SPF-colonized mice, which 
demonstrated significant collagen deposition and fibroblast activation, we identified several 
microbes that clustered tightly with fibrosis. This included Mucispirillum schaedleri, a 
mucous degrading organism that has been reported to discriminate between colitis and 
remission (28) in a mouse model but has not been linked to fibrosis. Ruminococcus are 
another group of mucolytic bacteria that have been observed to be increased in CD in some 
studies, associated with the stricturing phenotype in a recent pediatric CD study, and 
contribute to experimental colitis (22, 29, 30, 44). Ruminococcus and M. schaedleri were 
capable of directly modulating fibroblast function in vitro. Therefore, further studies 
demonstrating potential causal efficacy of these correlated organisms in vivo are warranted. 
It would be interesting to assess in future studies whether M. schaedleri, or previously 
identified species of Ruminococcus, are present in Tl1a-Tg mice with fibrostenosis under 
colitic conditions and in CD patients with the high risk TNFSF15 haplotype and stricturing 
disease. Furthermore, it would be informative to assess mucus structure, mucosal barrier 
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function, and fibroblast activation in mice and humans with and without these mucous 
degrading organisms. Lastly, Anaeroplasma, a genus which has been previously associated 
with experimental colitis (31), was also significantly associated with fibrosis in the cecum of 
SPF-colonized mice. In terms of organisms that were associated with reduced fibrosis in the 
cecum, Coprococcus, a genus that has been reported to be depleted in patients with CD (34) 
was associated with reduced fibrosis in both, mice reconstituted with SPF microbiota and 
human microbiota. Oscillospira have been associated with gut health, and their reduced 
abundance has been implicated in a variety of diseases including CD (47). Notably, 
compared with positively correlated organisms, Oscillopsira mitigated fibroblast function in 
vitro.
In the ileum of SPF-colonized mice, we observed that there were competing sets of microbes 
associated with either enhanced or reduced fibrosis severity. It is worth noting that ileal 
inflammation may have impacted the microbial variations and associations with fibrosis 
seen, compared with the cecum which had very tight microbial associations with fibrosis in 
the context of no significant inflammation. Members of the Streptococcus and Lactobacillus 
genera were found to be positively associated with fibrosis in the ileum. This is concordant 
with recent human data indicating that fecal abundance of these microbes is associated with 
another fibrotic complication of IBD, primary sclerosing cholangitis (32). Many organisms 
that were associated with reduced fibrosis in SPF-colonized mice have previously been 
observed to be depleted in patients with CD, including Faecalibacterium prausnitzii, which 
has been well-described to have anti-inflammatory properties (29). Additionally, members of 
the Lachnospiraceae family, which contains many butyrate producers that are decreased in 
CD patients (33), were associated with reduced fibrosis in the ileum of SPF-colonized mice. 
To our knowledge, this is the first study to link these microbes not just to protection from 
inflammation, but also fibrotic disease. Thus, it would be important to determine 
mechanistically how these short-chain fatty acid producers affect intestinal fibrosis in 
addition to inflammation. One possibility is a direct effect of these microbes (or their 
products) on fibroblast function, as our data suggest.
Interestingly, our microbiome-fibrosis correlation studies also underscore the disjunction 
between inflammation and fibrosis noted above. Sulfite-reducing bacteria such as Bilophila 
have been associated with a pro-inflammatory T helper type 1 immune response and an 
ability to induce experimental colitis (35). Despite the potential pro-inflammatory effects of 
such bacteria, we found that Bilophila correlated with a reduction in fibrosis in the ileum of 
SPF-colonized mice. Thus, hydrogen sulfide, one of the metabolic products of these 
bacteria, may have opposing effects on intestinal inflammation compared with fibrosis (36, 
37).
To our knowledge, this is the first study that causally implicates the intestinal microbiome in 
intestinal fibrosis, demonstrating that Tl1a-mediated fibrosis is dependent upon specific 
bacteria or bacterial consortia and that those bacteria can directly affect fibroblast function. 
Thus, a focus on TL1A pathways acting in concert with the microbiome may identify future 
therapeutic targets for fibrostenosing Crohn’s disease.
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Materials and Methods
Gnotobiotic experiments
Tl1a-Tg (which have sustained TL1A expression) and WT mice, both on C57Bl/6 
background were re-derived into germ-free status and bred under sterile conditions at the 
National Gnotobiotic Rodent Resource Center, Chapel Hill, NC. Tl1a-Tg mice and WT 
littermates at 2-4 months of age were orally gavaged with 200 uL of a 1:10 suspension of 
stool from either Cedars-Sinai specific pathogen free (SPF) mice or a healthy human donor 
diluted in pre-reduced phosphate-buffered saline. Mice were euthanized after 2 months of 
colonization for assessment of intestinal fibrosis and histopathology. Mucosal areas of 
collagen deposition identified by Picrosirius red-stained gut sections were quantitated for the 
relative degree of fibrosis using ImageJ software, as previously described (27). Two animal 
pathologists scored H&E stained sections in a blinded manner using previously described 
histopathological scoring system used in GF experiments (38).
Fibroblast gap-closure assays
Mouse primary colonic fibroblasts were isolated as previously described (27). Equal 
numbers of fibroblasts per group (1×105 cells) were seeded in 8 chamber slides and cultured 
for 24-48h until a monolayer was formed. A scratch was created with a P200 pipette tip. Cell 
debris was removed by washing cells with PBS and then cell-culture medium was replaced 
with time-lapse images taken every 4 hours under an Olympus CK2 microscope at 100× 
magnification. The area of the gap between the two migrating fronts of the cells was 
quantified using ImageJ software and relative percent area of gap closed at the indicated 
time points was calculated as (area t0 – area tx)/area t0. For assays involving supplementation 
with cecal washings, cecal contents from native SPF WT and GF mice were released by 
flushing with 1 ml of distilled deionized water, as previously described (38). The washings 
were then homogenized by vortexing, and pelleted by centrifugation. Supernatant were 
collected, filtered through a 0.22 μm filter, and was added directly to the cells after simulated 
wound, at a 1:20 dilution (5% volume). In the indicated assays, mouse recombinant Tl1a 
(R&D Systems, Minneapolis, MN) was added at a concentration 100 ng/ml for 4 hours prior 
to simulated wound and then maintained during the indicated migration period. For assays 
involving the addition of bacterial lysates, Oscillospira sp., Mucispirillum schaedleri and 
Ruminococcus gnavus were cultured anaerobically on chocolate blood agar. Fresh bacterial 
colonies were resuspended in sterile PBS and lysed. After simulated wound, 25 μg/ml lysate 
was added to the culture chamber, as describe previously (35). Cell migration was assessed 
after 16 h of incubation.
For fibroblast adhesion assays, an equal number of cells were seeded into 24-well plates and 
allowed to settle for either 20 or 80 minutes, after which the wells were washed twice with 
PBS to remove nonadherent cells. Adherent cells were counted for 5 visual fields/well 
(representing four quadrants and the center of the well) at 200× magnification, then 
averaged. The average number of adherent cells per visual field is then displayed for each 
well.
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Histological myofibroblast quantification
Fibroblast and myofibroblasts were quantified by anti-vimentin and anti-α-Smooth Muscle 
Actin immunofluorescence-stained OCT tissue sections. 4 μm frozen sections were fixed 
with 10% formalin, blocked in 10% BSA, 0.1% Triton X-100 TBST, and stained overnight 
at 4 degree C with primary antibodies: rabbit polyclonal anti-αSMA Ab (Abcam, 
Cambridge, MA) at 1:100 dilution and chicken polyclonal anti-Vimentin Ab (Abcam, 
Cambridge, MA) at 1:2000 dilution. Secondary antibody at 1:500 dilution was added for 2 
hours at room temperature with donkey anti-rabbit IgG-Alexa-fluor-647 and goat anti-
chicken IgY- DyLight 488 (Abcam, Cambridge, MA). Images were captured with Leica 
TCS spectral microscope. Total numbers and percentage of myofibroblasts (that colocalize 
fluorescence) over total vimentin-positive cells per HPF in ileum or cecum were quantitated 
by two independent investigators.
Quantitative real-time PCR analysis
Total RNA was isolated from cultured fibroblasts using Qiagen RNeasy Micro Kit according 
to the manufacturer’s protocol. Two-hundred and fifty nanograms of total RNA was used in 
each RT reaction, with oligo(dT) as primer, using the Omniscript kit and protocol (Qiagen). 
Collagen 1a2 and β-actin transcripts were amplified by quantitative real-time RT-PCR with 
TaqMan probes and primers (ThermoFisher Scientific, Waltham MA, USA). PCR was done 
on 1/4 the RT reaction in duplicate as follows: 50°C for 2 min, 95°C for 2 min, then 45 
cycles at 95°C for 15 s, and 60°C for 1 min. Assays were performed following the 
predeveloped TaqMan assay reagents protocol for Platinum qPCR mix (Invitrogen Life 
Technologies) in a Mastercycler Ep realplex2 (Eppendorf). The Mastercycler System 
Interface was used to analyze samples. Duplicates differing by less than one cycle were 
averaged and amount of transcript was analyzed. Replicate Ct values were normalized to 
replicate reference gene (β- actin) Ct values (ΔCt), and relative expression was calculated 
with respect to the indicated reference sample (ΔΔCt), expressed as percentage of β-actin.
Microbial correlation with fibrosis—Cecal and ileal luminal content was released by 
flushing with distilled deionized water then the mucosa-associated bacteria were released by 
DTT treatment according to our published protocol (38). DNA extraction and sequencing of 
the 16S ribosomal RNA gene was then performed for luminal and mucosal samples as 
previously described (39). In brief, bacterial DNA was extracted using the MO BIO 
Powersoil kit with bead beating. The V4 region of the 16S gene was amplified and barcoded 
using 515f/806r primers then 150×2 bp sequencing was performed on an Illumina HiSeq 
2500. Raw data was processed in QIIME 1.9.1 and 97% operational taxonomic units (OTUs) 
were identified by closed reference OTU picking against the Greengenes database (40). 
OTUs associated with fibrosis were identified using DESeq2, an algorithm that employs 
multivariate negative binomial models to identify differentially abundant features (41). 
Separate analyses were performed of the cecum and ileum of humanized and SPF colonized 
ex-GF mice. The models included fibrosis score by Sirius Red staining and sample type, sex, 
and TL1a genotype as covariates. Results were adjusted for multiple hypothesis testing (42). 
OTUs with adjusted p-values <0.05 were inputted into CoNet along with fibrosis scores to 
generate co-occurrence networks (43). This analysis involved four metrics (Spearman 
correlation, Bray Curtis dissimilarity, Jensen Shannon dissimilarity, scaled variance of log 
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ratios) from which a merged p-value was obtained by Fisher’s method and corrected with 
the Benjamini-Hochberg method. The resulting network was visualized in Cytoscape 3.2.1 
(http://cytoscape.org) with an edge-weighted, spring-embedded layout.
Statistics—Data are presented as dot plots and means with group differences tested using 
standard methods depending on variables measured: Student’s t-test for comparisons 
between two groups or Mann Whitney test for comparisons between two groups requiring 
non-parametric testing. When indicated, 1-way Analysis of Variance (ANOVA) with 
Tukey’s honestly significant difference (HSD) test for multiple comparisons was used. In all 
settings, a P value of less than 0.05 indicated a statistically significant difference in the 
parameter being compared. Additional statistical methods were used for microbial 
correlations with fibrosis, as described.
Study approval—This study was carried out in strict accordance with the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health. Animal studies 
were approved by the CSMC Animal Care and Use Committee, under IACUC protocol 
4942.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The intestinal microbiome is required for Tl1amediated location and degree of 
intestinal inflammation and collagen deposition
A-B) Representative H&E stains of ileal and cecal sections of 5-month-old WT and Tl1a-Tg 
mice, raised in germ free and native SPF conditions. C-D) Representative Sirius red staining 
of collagen deposition in ileal and cecal sections of 5-month-old WT and Tl1a-Tg mice, 
raised in GF and native SPF conditions. Dot plots with means displayed; n = 7-10 mice per 
group. * indicates p<0.05; ** p<0.01.
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Figure 2. The intestinal microbiome is required for Tl1a-enhanced fibroblast migration
A) Representative images of gap-closure assay after simulated wound shown for WT and 
Tl1a-Tg mice under native (left) and GF conditions (right) at initial wound (upper panels) 
and after migration (lower panel). B) Relative % area of gap closed indicated for fibroblasts 
isolated from WT and Tl1a-Tg mice raised under native SPF or GF conditions with 4, 8, and 
12 hours of migration after initial wound. C) Relative % area of gap closed indicated for 
fibroblasts isolated from WT and Tl1a-Tg mice raised under native SPF conditions and 
supplemented with cecal washings from either native SPF or GF WT mice during 16 hours 
of migration after initial wound. D) Relative % area of gap closed indicated for fibroblasts 
isolated from native SPF WT mice and supplemented with cecal washings as in (C), or with 
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either of the cecal washings and recombinant mouse Tl1a (100ng/ml). Data points represent 
fibroblast isolation from individual mice and bars represent means. * indicates p<0.05, ** 
p<0.01, *** p<0.005.
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Figure 3. Tl1a-Tg mice have increased intestinal inflammation and collagen deposition in the 
presence of mouse microbiota, but not human intestinal microbiota
A-B) Representative H&E stains of ileal and cecal sections of WT and Tl1a-Tg mice, raised 
under germ free conditions and then gavaged with either human (Hu) or specific pathogen 
free (SPF) microbiota. C-D) Representative Sirius red staining of collagen deposition in ileal 
and cecal sections of WT and Tl1a-Tg mice, raised under germ free conditions and then 
gavaged with either Hu or SPF microbiota. Dot plots with means displayed; n = 7-10 mice 
per group. * indicates p<0.05; ** p<0.01.
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Figure 4. Tl1a-Tg mice have increased fibroblast activation in the presence of mouse microbiota, 
but not human intestinal microbiota
Immunofluorescent staining of vimentin (green) and αSMA (red) from cecal (A) and ileal 
(C) sections of 5-month-old WT and Tl1a-Tg mice raised in germ free conditions and then 
gavaged with either Hu or SPF microbiota. White arrows denote myofibroblasts that co-
localize vimentin and αSMA at 400× magnification. Total numbers and percentage of 
myofibroblasts over total vimentinpositive cells per individual HPF in cecum (B) or ileum 
(D) were quantitated and displayed as dot plots with means. Pooled data of total individual 
HPFs, representative of 4-6 mice per group. * indicates p<0.05; ** p<0.01.
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Figure 5. Microbial networks associated with cecal and ileal fibrosis in germ-free mice colonized 
with SPF or Hu microbiota
A) Microbes associated with fibrosis in DESeq2 models were used to construct 
cooccurrence/ co-exclusion networks with fibrosis score. Networks were constructed in 
Cytoscape with an edge-weighted, spring-embedded layout, which groups nodes with highly 
interconnected nodes. Diamonds represent OTUs, colored by association with fibrosis: green 
(associated with increased fibrosis), red (associated with reduced fibrosis), gray (indirect 
association only). Letters indicate the genus of fibrosis-associated OTUs; unmarked OTUs 
are unclassified members of the Clostridiales order. Similar network plots were constructed 
for fibrosis in the ileum of SPF colonized mice (B), cecum of Hu mice (C), and ileum of Hu 
mice (D). In (B), the names and numbers of OTUs associated with reduced fibrosis are 
shown next to a dense cluster in which it is difficult to discern individual OTUs. OTUs that 
are unclassified members of microbial families are indicated with (f).
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Figure 6. Differential effects of bacteria positively or negatively correlated with fibrosis on 
fibroblast migration and collagen expression
A) Representative images of gap-closure assay after simulated wound on fibroblasts isolated 
from native WT mice at initial wound (upper panels) and after migration (lower panel) in the 
presence of bacterial lysates. B) Relative % area of gap closed for fibroblasts isolated from 
native WT mice and supplemented with indicated bacterial lysates (25 μg/ml) during 
migration. Data points represent fibroblast isolation from individual mice and bars represent 
means. C) Relative expression of collagen from fibroblasts in (B) after migration in the 
presence of the specified bacterial lysates. Data are represented as means ± SD; * indicates 
p<0.05, ** p<0.01, *** p<0.005.
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